Evolus, Inc. (LON:0K16)
London flag London · Delayed Price · Currency is GBP · Price in USD
14.58
+0.43 (3.00%)
At close: Jan 31, 2025

Evolus Revenue

Evolus had revenue of $68.52M USD in the quarter ending March 31, 2025, with 15.49% growth. This brings the company's revenue in the last twelve months to $275.46M, up 25.38% year-over-year. In the year 2024, Evolus had annual revenue of $266.27M with 31.76% growth.

Revenue (ttm)
$275.46M
Revenue Growth
+25.38%
P/S Ratio
2.09
Revenue / Employee
$829.71K
Employees
332
Market Cap
446.26M GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024266.27M64.19M31.76%
Dec 31, 2023202.09M53.47M35.98%
Dec 31, 2022148.62M48.94M49.10%
Dec 31, 202199.67M43.13M76.29%
Dec 31, 202056.54M21.62M61.89%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
AstraZeneca42.56B
GSK plc31.53B
Haleon11.23B
Smith & Nephew4.64B
ConvaTec Group1.83B
Hikma Pharmaceuticals2.50B
HUTCHMED (China)503.39M
Genus671.60M
Revenue Rankings